MOSES IKEJIOFOR: Open Payments
NPI 1437704103 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 7 payments from 5 companies in 2025. Trend: 2023 $21 · 2024 $22 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VRAYLAR, Qelbree, Jornay PM, ABILIFY MAINTENA, COBENFY.
Industry payments across MD — which companies pay providers there.
